(NaturalHealth365) Since at least April 2021, officials (including the Pfizer CEO himself) have hinted at the eventual need for a COVID shot booster, thanks to so-called virus variants and the waning effectiveness of these experimental drugs.
But as Pfizer prepares to seek Emergency Use Authorization (EUA) for its booster mRNA jab, a stunning revelation from a team of Spanish researchers sheds a worrisome light on these jabs’ true ingredients. So what have millions of people been unknowingly exposed to as a result of this massive drug trial?
URGENT: mRNA jabs contain high levels of toxic chemical called graphene oxide, says diverse team of Spanish researchers
According to its official EUA fact sheet, the Pfizer shot contains the following ingredients: mRNA, lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 2 [(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3- phosphocholine, and cholesterol), potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose.
But there is something else not listed on this ingredients list: a toxic compound called graphene oxide.
A team of researchers from Spain recently used spectroscopy and electron microscope analysis to assess the contents of the COVID shot vials. Inside, they found “enormous doses” of this nanoparticle. Graphene oxide was identified in samples from all the major Big Pharma players, including AstraZeneca, Pfizer, Moderna, Sinovac, Janssen, and Johnson & Johnson. Certain COVID shot vials contained as much as 99% graphene oxide and not much else.
It’s not just the shots, either. In their research, the Spanish team also discovered graphene oxide in the swabs used in PCR and antigen tests. Graphene is even found in many conventional face masks.
It’s worth noting that in April 2021, the government of Canada explicitly urged people not to wear masks containing graphene due to the possibility that inhaling these nanoparticles “may pose health risks.” Graphene, says Canadian health officials, has been shown to cause lung toxicity in animals.
With so much concern surrounding this toxic compound, why is it being foisted upon the public en masse?
According to its safety data sheet, there is “no data available” on the various toxicological effects of graphene oxide, including acute toxicity, carcinogenicity, reproductive toxicity, and skin and eye damage. However, 2012 research published in the peer-reviewed journal ACS Nano concludes that inhaling these nanoparticles can cause lung inflammation and lead to lung cancer and pneumonia.
The Spanish researchers who discovered graphene oxide in COVID shots also note that this toxic compound can also:
Promote thrombus formation (blood clots)
Damage red blood cells
Damage the immune system
Inflame mucous membranes and contribute to a loss of taste or smell – or even lead to an unusual metallic taste in the mouth, which has been reported
Exert magnetic properties once inside an organism – which may explain the bizarre footage of people holding magnetic objects to their arms following their jabs
One reason why graphene oxide has such devastating effects on human health, explain the researchers, is that it depletes a natural antioxidant in the body called glutathione. Interestingly, numerous studies, including a comprehensive review published last year in Therapeutics and Clinical Risk Management, reveal that N-acetylcysteine (NAC), a precursor to glutathione, may help people with breathing problems.
We continue to be told repeatedly that the “benefits” of these COVID shots outweigh the risks, yet breaking news like this calls this propagandized assertion into question. What’s your opinion: do the benefits outweigh the risks of a COVID shot for you and your loved ones?
Researchers in the United States have shown that water-soluble derivatives of vitamin E (α-tocopherol) exhibit potent antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Kevin Harrod from the University of Alabama at Birmingham and colleagues found that the compounds synergized with the antiviral drug remdesivir to inhibit SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) – an enzyme that is crucial for transcription and replication of the viral genome.
Although intense research efforts to rapidly identify effective antiviral therapies have largely focused on repurposing existing drugs, only remdesivir has so far been authorized as a COVID-19 treatment, and its clinical benefits are modest.
“Here, we employed a novel artificial intelligence query of FDA-approved compounds for repurposing as antivirals against SARS-CoV-2 and identify tocopherol derivatives with potent antiviral activity and synergy with remdesivir,” writes Harrod and colleagues.
The team says the findings have important implications, given that many tocopherol derivatives are already considered safe for use in humans.
A pre-print version of the research paper is available on the bioRxiv* server, while the article undergoes peer review.
The need for broad-spectrum interventions
The emergence of several coronaviruses over recent years highlights the need for broad-spectrum interventional strategies.
Despite the unprecedented development and authorization of effective vaccines to protect against COVID-19, breakthrough SARS-CoV-2 infections, vaccine hesitancy, and the inequitable distribution of vaccines globally emphasize the need for therapeutic interventions that will limit severe disease and mortality.
Currently, the FDA-approved drug remdesivir is the only antiviral to have demonstrated improvement of clinical outcomes to date, albeit with limited effectiveness and the limitation of intravenous administration.
What did the researchers do?
Using an artificial-intelligence-driven in silico screen of FDA-approved compounds for repurposing as antivirals against SARS-CoV-2, the team identified almost 100 that they prioritized for in vitro screening.
This led to the identification of 12 compounds that reduced SARS-CoV-2 propagation by more than 90% at a concentration of just 10µM.
Next, the researchers found that five of these top 12 compounds reduced the burden of SARS-CoV-2 by more than 90% in the human lung epithelial cell line Calu3.
Four of these drugs – niclosamide, remdesivir, lopinavir, and D-α-tocopherol polyethylene glycol succinate (TPGS) – showed maximal efficacy in preventing established SARS-CoV-2 infection in VeroE6 cells.
In addition, 11 of the 12 top compounds demonstrated strong antiviral activity against the seasonal betacoronavirus OC43, suggesting that most of the compounds are effective against betacoronaviruses more broadly.
Water-soluble tocopherols inhibit the transcriptional activity of SARS-CoV-2 RNA-dependent RNA polymerase. A) Graph representing the fold change of SARS-CoV-2 genome in infected VeroE6 cells relative to initial uptake in the untreated control. Remdesivir and TPGS were given at a fully effective dose, 10 μM and 30 μM, respectively. Points and error bars represent the mean +/- SEM calculated from two technical replicates. B) Dose-response curves for the transcriptional activity of the SARS-CoV-2 replication complex treated with TPGS (blue) and remdesivir (red). The shaded region represents the 95% CI and points represent replicates from a single experiment. C) Dose-response curve for the transcriptional activity of the SARS-CoV- 2 replication complex treated with high concentrations of TPGS, with 50% activity (blue, dashed line) and the critical micelle concentration of TPGS (red, dashed line) indicated. The upper limit of the model was not fixed. Points represent replicates from a single experiment. D) Dose-response plot for increasing concentrations of αTOS (blue) and αTOP (red). Points represent replicates from a single experiment. E) Docking model of the most favorable pose for αTOS (white) interacting with conserved, hydrophobic residues (dark blue, named) within NSP7 (light blue). F) Docking model of the most favorable pose for αTOS (white) interacting with conserved, hydrophobic residues (dark green, named) within NSP8 (light green). G) Representation of the heterotetrameric structure of NSP7 (light blue) and NSP8 (light green) with the most favorable poses of αTOS interacting individually with each NSP7 (dark blue) and NSP 8 (dark green) superimposed.
Screening the compounds for synergistic combinations
When Harrod and colleagues screened the top compounds for synergistic combinations, they found that a combination of remdesivir and TPGS resulted in an 8-fold increase in antiviral potency.
To understand the mechanism underlying the antiviral activity of TPGS, the researchers tested its constituent components: D-α-tocopherol, succinate, and polyethylene glycol.
Since α-tocopherol alone is insoluble in an aqueous environment, the researchers instead tested α-tocopherol succinate (αTOS) and α-tocopherol phosphate (αTOP).
This revealed that αTOS is capable of inhibiting SARS-CoV2 replication in VeroE6 cells, suggesting that α-tocopherol is the active antiviral component in TPGS.
Given the potent synergy observed between TPGS and remdesivir – which is a known inhibitor of the SARS-CoV-2 RdRp – the team hypothesized that TPGS also inhibits this RdRp.
The researchers measured the ability of TPGS to inhibit the transcriptional activity of purified SARS-CoV-2 RdRp composed of the catalytic subunit non-structural protein 12 (NSP12) and two accessory proteins – NSP7 and NSP8.
They found that TPGS inhibited the transcriptional activity of the SARS-CoV-2 RdRp, with a potency that was approximately 100-fold that of remdesivir.
RdRp had high-affinity binding sites for αTOS
To further elucidate the interaction between the water-soluble tocopherols and the SARS-CoV-2 RdRp, the team performed computational docking studies across the individual components of the RdRp.
This identified high-affinity binding sites for αTOS within each of NSP7, NSP8, and NSP12.
Interestingly, while the top poses for αTOS were identified at a few surface locations across NSP12, all top poses for αTOS interacting with NSP7 and NSP8 localized to a single region within each protein, thereby providing greater confidence in their relevance.
In each case, the most favorable binding poses localized with residues seen in one of two recently described hydrophobic interfaces required for the assembly of functional RdRp.
“Taken together, these findings strongly support a mechanism by which TPGS prevents or destabilizes the assembly of the SARS-CoV-2 RdRp,” writes Harrod and colleagues.
TPGS as an effective antiviral against SARS-CoV-2
The researchers say the study has identified TPGS as an effective antiviral against SARS-CoV-2 and β-coronaviruses more broadly that also displays strong synergy with remdesivir.
“These findings are significant given that many tocopherol derivatives, including TPGS, are considered safe for humans, are orally bioavailable, and dramatically enhance the activity of the only approved antiviral for SARS-CoV-2 infection,” concludes the team.
bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information. Journal reference:
Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.
Saxon Warrior LoanRangerSeattle • 2 days agoAvoid inflammatory foods. Avoid processed foods. Take natural herbal remedies. Boost up on vitamins and minerals especially ones that boost the immune system such as Vitamin D3, l-ascorbate Vitamin C, zinc, selenium, and magnesium . Detox in a borax bath or in a bath containing alfalfa pods. Try drinking pine needles tea. Drink distilled water frequently to remove toxins. Dandelion extract may be useful. Avoid any exposure to 5g radiation at all costs. Pray to God.
Baby LoanRangerSeattle • 10 hours agoLoanRangerSeattle There is probably nothing you can do to convince “true believers”. Sooner or later they will pay the price for their ignorance in the form of a blood clot or paralysis. They are likely ardent CNN viewers so they are a lost cause. Pray for them.
A Health Impact News subscriber from Europe reminded us that this database maintained at EudraVigilance is only for countries in Europe who are part of the European Union (EU), which comprises 27 countries.
The total number of countries in Europe is much higher, almost twice as many, numbering around 50. (There are some differences of opinion as to which countries are technically part of Europe.)
So as high as these numbers are, they do NOT reflect all of Europe. The actual number in Europe who are reported dead or injured due to COVID-19 shots would be much higher than what we are reporting here.
The EudraVigilance database reports that through July 3, 2021 there are 17,503 deaths and 1,687,527 injuries reported following injections of four experimental COVID-19 shots:
From the total of injuries recorded, half of them (837,588 ) are serious injuries.
“Seriousness provides information on the suspected undesirable effect; it can be classified as ‘serious’ if it corresponds to a medical occurrence that results in death, is life-threatening, requires inpatient hospitalisation, results in another medically important condition, or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, or is a congenital anomaly/birth defect.”
As we reported yesterday, tens of thousands of people in the U.S. now regret getting the COVID-19 shots, and are begging for help, because the medical system has turned its back on them and refuses to treat their injuries. See:
One subscriber from the UK commented on the article and stated that the same thing was happening there:
It is exactly the same in Scotland and England.
My vaccinated friends are not getting appointments with their family doctors who are avoiding them post vaccination even although there are no patients in the GP surgery waiting rooms when they have tried to get appointments. It is utterly cruel given they talked them into getting the vaccinations and accepted 10 UK pounds from the Scottish and English governments per person vaccinated on their patient list and did not disclose the risk of these vaccinations to the patients.
A friend nearly passed out close to the GP surgery, a kind stranger wheeled her up to the GP surgery and she was not allowed to be seen by her GP because she did not have an appointment. The nurse refused to take bloods because they are not allowed to do so until management confirms they can do this so they cannot even do exploratory bloods to investigate what has gone wrong with these patients post vaccination.
Another friend’s hospital consultant phoned a friend’s GP insisting her family doctor see her given she had had heart procedures and no appointments for 2 years. She told me after first Pfizer shot “it was like acid going into my veins” and the queen did not get the same vaccine asshe did which will be completely true. Her GP treated her with disdain and was not pleased to see her and my friend also tells me that every time she walks now post vaccination her heart races and her son has been unwell post vaccination too.
All my friends who got the vaccination have had severe worsening of their pre-existing medical conditions and some have got heart conditions they did not previously have or chronic obstructive airways disease.
I have noticed most have became irritable and short-tempered as they are becoming unwell not realising the vaccine is harming them and they are lashing out at others for no good reason.
In UK, NHS contributions are deducted from people’s salaries and the retired paid these all their working life and now are getting refused service but they will still take these NHS contributions regardless. It is wicked and cruel. Though it is the governments who are instructing the GP and hospital management to treat the patients in this abysmal manner.
I am quite sure this will be happening in most if not all countries.
God be with us all.
A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. This subscriber has volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.
Since we have started publishing this, others from Europe have also calculated the numbers and confirmed the totals.*
Here is the summary data through July 3, 2021.
Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2,Comirnaty) from BioNTech/ Pfizer: 8,426 deaths and 632,623 injuries to 03/07/2021
17,754 Blood and lymphatic system disorders incl. 99 deaths
14,858 Cardiac disorders incl. 1,165 deaths
126 Congenital, familial and genetic disorders incl. 12 deaths
227,408 General disorders and administration site conditions incl. 1,009 deaths
607 Hepatobiliary disorders incl. 32 deaths
3,359 Immune system disorders incl. 14 deaths
19,508 Infections and infestations incl. 247 deaths
8,912 Injury, poisoning and procedural complications incl. 94 deaths
18,352 Investigations incl. 88 deaths
10,315 Metabolism and nutrition disorders incl. 50 deaths
131,547 Musculoskeletal and connective tissue disorders incl. 50 deaths
379 Neoplasms benign, malignant and unspecified (incl. cysts and polyps) incl. 9 deaths
180,575 Nervous system disorders incl. 612 deaths
279 Pregnancy, puerperium and perinatal conditions incl. 5 deaths
117 Product issues
16,000 Psychiatric disorders incl. 33 deaths
3,045 Renal and urinary disorders incl. 33 deaths
8,593 Reproductive system and breast disorders
28,994 Respiratory, thoracic and mediastinal disorders incl. 447 deaths
39,173 Skin and subcutaneous tissue disorders incl. 25 deaths
866 Social circumstances incl. 5 deaths
754 Surgical and medical procedures incl. 16 deaths
19,209 Vascular disorders incl. 283 deaths
Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 601 deaths and 44,486 injuries to 03/07/2021
405 Blood and lymphatic system disorders incl. 18 deaths
659 Cardiac disorders incl. 73 deaths
16 Congenital, familial and genetic disorders
250 Ear and labyrinth disorders
10 Endocrine disorders incl. 1 death
518 Eye disorders incl. 3 deaths
4,283 Gastrointestinal disorders incl. 25 deaths
11,832 General disorders and administration site conditions incl. 150 deaths
58 Hepatobiliary disorders incl. 4 deaths
161 Immune system disorders incl. 1 death
598 Infections and infestations incl. 16 deaths
413 Injury, poisoning and procedural complications incl. 8 deaths
2,420 Investigations incl. 39 deaths
225 Metabolism and nutrition disorders incl. 11 deaths
7,687 Musculoskeletal and connective tissue disorders incl. 17 deaths
18 Neoplasms benign, malignant and unspecified (incl. cysts and polyps)
9,547 Nervous system disorders incl. 76 deaths
15 Pregnancy, puerperium and perinatal conditions incl. 1 death
11 Product issues
459 Psychiatric disorders incl. 5 deaths
150 Renal and urinary disorders incl. 8 deaths
166 Reproductive system and breast disorders incl. 1 death
1,453 Respiratory, thoracic and mediastinal disorders incl. 47 deaths
1,125 Skin and subcutaneous tissue disorders incl. 2 deaths
91 Social circumstances incl. 3 deaths
393 Surgical and medical procedures incl. 27 deaths
1,523 Vascular disorders incl. 65 deaths
*These totals are estimates based on reports submitted to EudraVigilance. Totals may be much higher based on percentage of adverse reactions that are reported. Some of these reports may also be reported to the individual country’s adverse reaction databases, such as the U.S. VAERS database and the UK Yellow Card system. The fatalities are grouped by symptoms, and some fatalities may have resulted from multiple symptoms.